EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation

Elisenda Alari-Pahissa, Judith Federico-Vega, Michelle Ataya, Anna Buxeda, Víctor Bello-Rico, Javier Gimeno, José Yélamos, Mireia Altadill, Sara Sanz-Ureña, Marta Riera, Carla Burballa, Betty Chamoun und 5 weitere

American Journal of Transplantation · 2025-08 · 25 (8) · 1657-1669

DOI: 10.1016/j.ajt.2025.04.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2025-08. Verfasst von Elisenda Alari-Pahissa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain; RICORS 20…. Hauptthemen laut MEDLINE: Kidney Transplantation, Killer Cells, Natural, Graft Rejection, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, European Commission, Fundació la Marató de TV3.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibitory killer cell immunoglobulin-like receptors (iKIRs) are randomly expressed by natural killer (NK) cell subsets and recognize motifs shared by HLA class-I (HLA-I) allotypes. Such interactions prevent NK cell autoreactivity while enhancing their response against cells lacking those HLA-I molecules (missing self), a situation defined in transplantation as iKIR-HLA-I mismatch (iKIR-MM), whose genotypic prediction has been associated with microvascular inflammation (MVI). Herein, we compared iKIR-MM in kidney transplant recipients with MVI ≥2 (n = 19) and controls with MVI ≤1 (n = 36). In parallel to genetic analysis of iKIR-MM, which was more frequent in MVI ≥2 patients, putative alloreactive iKIR-MM NK cells were defined by flow cytometry as NKG2A(-) cells bearing self-specific but lacking donor-specific iKIR. Although iKIR-MM NK cells were detected in both groups, their pretransplant numbers were higher in MVI ≥2 patients (median = 11.02, interquartile range = 0-58.31 vs median = 0, interquartile range = 0-9.46), especially in the presence of donor-specific antibodies or C4d, and correlated with MVI grade. Pretransplant, a subset of MVI ≥2 patients showed high proportions and numbers of oligoclonal iKIR-MM NK cells, which displayed an NKG2C(+) adaptive phenotype associated with cytomegalovirus infection. This pilot study provides a novel perspective on the contribution of iKIR-MM NK cells to MVI, with potential practical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationKiller Cells, NaturalGraft RejectionInflammationKidney Failure, ChronicAdaptive ImmunityHumansMaleFemaleMiddle AgedAdultGraft SurvivalFollow-Up StudiesPrognosisKidney Function TestsGlomerular Filtration RateCase-Control StudiesAllografts

Stichwörter der Autor:innen

KIR-HLA-I mismatchantibody-mediated rejectionkiller cell immunoglobulin-like receptorsmicrovascular inflammationnatural killer cellsrenal transplant

Autor:innen und Institutionen

  • Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain; RICORS 2040-Renal, Barcelona, Spain. Electronic address: ealari@researchmar.net.
  • Hospital del Mar Research Institute, Barcelona, Spain; Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain; RICORS 2040-Renal, Barcelona, Spain.
  • Department of Medicine and Life Sciences, Pompeu Fabra University, Barcelona, Spain.
  • Hospital del Mar Research Institute, Barcelona, Spain; RICORS 2040-Renal, Barcelona, Spain; Nephrology Service, Hospital del Mar, Barcelona, Spain.
  • Instituto de Investigación Sanitaria Puerta de Hierro, Majadahonda, Spain.
  • Pathology Service, Hospital del Mar, Barcelona, Spain.

Förderung

  • Instituto de Salud Carlos III
  • European Commission
  • Fundació la Marató de TV3
  • European Regional Development Fund
  • Agencia Estatal de Investigación
  • Sociedad Española de Nefrología
  • Ministerio de Sanidad, Consumo y Bienestar Social

Zitieren

APA

Alari-Pahissa, E., Federico-Vega, J., Ataya, M., Buxeda, A., Bello-Rico, V., Gimeno, J., Yélamos, J., Altadill, M., Sanz-Ureña, S., Riera, M., Burballa, C., Chamoun, B., Pérez-Sáez, M. J., Redondo-Pachón, D., Vilches, C., Crespo, M., & López-Botet, M. (2025). Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation. American Journal of Transplantation, 25(8), 1657-1669. https://doi.org/10.1016/j.ajt.2025.04.024

Vancouver

Alari-Pahissa E, Federico-Vega J, Ataya M, Buxeda A, Bello-Rico V, Gimeno J, et al. Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation. American Journal of Transplantation. 2025;25(8):1657-1669. doi:10.1016/j.ajt.2025.04.024

BibTeX
@article{AlariPahissa2025,
  author = {Alari-Pahissa, Elisenda and Federico-Vega, Judith and Ataya, Michelle and Buxeda, Anna and Bello-Rico, Víctor and Gimeno, Javier and Yélamos, José and Altadill, Mireia and Sanz-Ureña, Sara and Riera, Marta and Burballa, Carla and Chamoun, Betty and Pérez-Sáez, María José and Redondo-Pachón, Dolores and Vilches, Carlos and Crespo, Marta and López-Botet, Miguel},
  title = {Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation},
  journal = {American Journal of Transplantation},
  year = {2025},
  volume = {25},
  number = {8},
  pages = {1657--1669},
  doi = {10.1016/j.ajt.2025.04.024}
}
Kostenlos starten →